WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of ($0.42), $0.06 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $290 thousand versus the consensus estimate of $8.73 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.